IsoPlexis Corporation
IsoPlexis Corporation (ISO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ISO · as of Jun 9, 2026
Key Statistics
Explore IsoPlexis Corporation Data
iso stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 4 · Buy rate: 50.0%
Competitors & Peers
iso competitorsISO
ALLK
ANGN
ANPC
ELUT
HEXOStock Performance
Full HistoryAbout IsoPlexis Corporation
IsoPlexis Corporation is a life sciences company dedicated to advancing the development of novel curative treatments and personalized therapeutics. The company's innovative offerings serve a wide inte…
what is isoplexis corporation · iso stock overview · isoplexis corporation company profile · who is isoplexis corporation ceo · iso NASDAQ · isoplexis corporation headquarters · isoplexis corporation business segments
About Stock Overview & Key Data
IsoPlexis Corporation (ISO) is a Healthcare company in the Medical - Devices industry, listed on NASDAQ since Oct 8, 2021. As of the latest trading session, ISO stock price is $0.76, with a market capitalization of $30.3M. The stock has returned -68.27% over the past 12 months and -50.86% year-to-date.
According to 4 Wall Street analysts, the consensus rating for IsoPlexis Corporation stock is Buy, with an average 12-month price target of $—. In fiscal year 2022, IsoPlexis Corporation reported revenue of $16.8M and net income of -$115.5M. For detailed data — including IsoPlexis Corporation revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, IsoPlexis Corporation (ISO) stock price is $0.76. The stock is traded on NASDAQ under the ticker symbol ISO. The 52-week range is $0.60 – $3.84.